Previous 10 | Next 10 |
Apyx Medical Corporation (APYX) Q3 2019 Earnings Conference Call November 11, 2019 4:30 PM ET Company Participants Charlie Goodwin - President & Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Lucas Baranowski - Craig-Hallum Capita...
Gainers: BREW +122.2% . KDMN +18.1% . ICUI +11.1% . APYX +6.8% . GO +6.6% . More news on: Craft Brew Alliance, Inc., Kadmon Holdings, Inc., ICU Medical, Inc., Stocks on the move, Read more ...
Advanced Energy Sales of $6.1 million in Q3, up 104% year-over-year Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic sur...
Apyx Medical Corporation , formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and as J-Plasma® in t...
Apyx Medical Corporation , formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and as J-Plasma ® ...
Apyx Medical Corporation , formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion ® in the cosmetic surgery market and as J-Plasma ® ...
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the hospital surgical market, today announced...
Apyx Medical Corporation , formerly Bovie Medical Corporation, (NASDAQ:APYX) (the “Company”), a maker of medical devices and supplies and the developer of its Helium Plasma Technology, marketed and sold as Renuvion® in the cosmetic surgery market and J-Plasma® in the ...
Apyx Medical Corp (APYX) Q2 2019 Earnings Conference Call August 08, 2019, 16:30 ET Company Participants Charlie Goodwin - President and CEO Tara Semb - CFO Conference Call Participants Matt Hewitt - Craig-Hallum Capital Group Kyle Bauser - Dougherty & Company Russell...
Thinly traded micro cap Apyx Medical ( APYX +11.3% ) is up on over 60% higher volume, albeit on turnover of only 287K shares, following its Q2 report released after the close yesterday. Highlights: More news on: Apyx Medical Corporation, Healthcare stocks news, Earnings news and commen...
News, Short Squeeze, Breakout and More Instantly...
Apyx Medical Corporation Company Name:
APYX Stock Symbol:
NASDAQ Market:
Apyx Medical Corporation Website:
Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency platform technology marketed and sold as Renuvion ® , today announced that financial results for the second quarter of fiscal year 2024 will be relea...
Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health PR Newswire Renuvion is the only device FDA-cleared for contracting subcutaneous tissue CLEARWATER, Fla. ...